MX2024008983A - Polipeptidos quimericos - Google Patents
Polipeptidos quimericosInfo
- Publication number
- MX2024008983A MX2024008983A MX2024008983A MX2024008983A MX2024008983A MX 2024008983 A MX2024008983 A MX 2024008983A MX 2024008983 A MX2024008983 A MX 2024008983A MX 2024008983 A MX2024008983 A MX 2024008983A MX 2024008983 A MX2024008983 A MX 2024008983A
- Authority
- MX
- Mexico
- Prior art keywords
- amino acid
- polypeptide
- gingipain
- lys
- arg
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0216—Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Gram-negative bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/22—Cysteine endopeptidases (3.4.22)
- C12Y304/22037—Gingipain R (3.4.22.37)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/22—Cysteine endopeptidases (3.4.22)
- C12Y304/22047—Gingipain K (3.4.22.47)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2022900101A AU2022900101A0 (en) | 2022-01-20 | Chimeric polypeptides | |
| PCT/AU2023/050028 WO2023137519A1 (en) | 2022-01-20 | 2023-01-20 | Chimeric polypeptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024008983A true MX2024008983A (es) | 2024-11-08 |
Family
ID=87347480
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024008983A MX2024008983A (es) | 2022-01-20 | 2024-07-19 | Polipeptidos quimericos |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP4466011A4 (https=) |
| JP (1) | JP2025503079A (https=) |
| KR (1) | KR20240149404A (https=) |
| CN (1) | CN118891059A (https=) |
| AU (1) | AU2023209795A1 (https=) |
| CA (1) | CA3248847A1 (https=) |
| IL (1) | IL314282A (https=) |
| MX (1) | MX2024008983A (https=) |
| WO (1) | WO2023137519A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025019900A1 (en) * | 2023-07-26 | 2025-01-30 | Denteric Pty Ltd | Chimeric protein vaccine |
| WO2025019901A1 (en) * | 2023-07-26 | 2025-01-30 | Denteric Pty Ltd | Rna vaccines |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPQ485999A0 (en) * | 1999-12-24 | 2000-02-03 | Csl Limited | P. gingivalis antigenic composition |
| DK2328914T3 (en) * | 2008-08-29 | 2017-07-10 | Oral Health Australia Pty Ltd | Prevention, treatment and diagnosis of P. gingivalis infection |
| WO2014183168A1 (en) * | 2013-05-14 | 2014-11-20 | Oral Health Australia Pty Ltd | Inhibitory propeptides |
-
2023
- 2023-01-20 IL IL314282A patent/IL314282A/en unknown
- 2023-01-20 CN CN202380027380.5A patent/CN118891059A/zh active Pending
- 2023-01-20 WO PCT/AU2023/050028 patent/WO2023137519A1/en not_active Ceased
- 2023-01-20 JP JP2024543301A patent/JP2025503079A/ja active Pending
- 2023-01-20 CA CA3248847A patent/CA3248847A1/en active Pending
- 2023-01-20 KR KR1020247027669A patent/KR20240149404A/ko active Pending
- 2023-01-20 AU AU2023209795A patent/AU2023209795A1/en active Pending
- 2023-01-20 EP EP23742622.6A patent/EP4466011A4/en active Pending
-
2024
- 2024-07-19 MX MX2024008983A patent/MX2024008983A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP4466011A1 (en) | 2024-11-27 |
| CN118891059A (zh) | 2024-11-01 |
| WO2023137519A1 (en) | 2023-07-27 |
| KR20240149404A (ko) | 2024-10-14 |
| EP4466011A4 (en) | 2026-04-08 |
| AU2023209795A1 (en) | 2024-08-01 |
| CA3248847A1 (en) | 2023-07-27 |
| JP2025503079A (ja) | 2025-01-30 |
| IL314282A (en) | 2024-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2024008983A (es) | Polipeptidos quimericos | |
| AR108442A1 (es) | Proteínas de fusión gdf15 y usos de estas | |
| MX2024015050A (es) | L-asparaginasa modificada | |
| PE20120021A1 (es) | Mutantes fgf21 | |
| AR123978A1 (es) | Variantes de la interleucina-18 y métodos de uso | |
| PE20130041A1 (es) | Proteinas de dominio de andamiaje de fibronectina que se unen a interleucina 23 (il-23) | |
| PE20231439A1 (es) | Proteinas f de hmpv estabilizadas por prefusion | |
| MX2009004147A (es) | Vacunas de peptido para canceres que expresan polipeptidos mphosph1 o depdc1. | |
| CO2021014778A2 (es) | Subunidad s1 modificada de la proteína de espícula de coronavirus | |
| MX339277B (es) | Agente inductor de inmunidad. | |
| AR076977A1 (es) | Proteinas precursoras repetitivas autoensambladas | |
| CL2011003121A1 (es) | Proteína de fusión que comprende una secuencia de hormona de crecimiento (gh), ligada a un polipéptido recombinante extendido (xten) que comprende al menos 200 aminoácidos, carece de epítopes de células t y los residuos g, a, s, t, e y p suman más del 90%; ácido nucleico, vector y célula; método de producción; composición farmacéutica y uso. | |
| AR069996A1 (es) | Plantas con caracteristicas aumentadas relacionadas con el rendimiento y un metodo para desarrollar las mismas | |
| AR071874A1 (es) | Proteinas de dominio de armazon basadas en fibronectina multivalentes | |
| ES2691539T3 (es) | Luciferasas de Oplophorus sintéticas con mayor emisión de luz | |
| EA201592306A1 (ru) | Вакцины против вируса гриппа и их применения | |
| BRPI0606612A2 (pt) | expressão recombinante de proteìnas em uma forma de duas cadeias ligadas por dissulfeto | |
| PE20160507A1 (es) | Diferenciacion de celulas madre mesenquimales | |
| AR076349A1 (es) | Peptido auxiliar del antigeno del cancer | |
| CO6220834A2 (es) | Composiciones y metodos de aplicacion topica y suministro transdermico de toxinas botulinum estabilizadas con fragmentos de polipeptido derivado de hiv-tat | |
| AR114960A1 (es) | Proteína tolerante a herbicida, gen codificante y uso de la misma | |
| CO2022014871A2 (es) | Polipéptidos variantes proteolíticamente estables de u1-agatoxina-ta1b para el control de plagas | |
| BR112018003594A2 (pt) | cadeia pesada de imunoglobulina recombinante, anticorpos, método de produção de conjugado e conjugados | |
| AR123187A1 (es) | Vacuna de múltiples epítopos para el tratamiento de la enfermedad de alzheimer | |
| AR116876A1 (es) | Vacuna de ibv 4/91 con proteína espicular heteróloga |